Summary by Futu AI
Christopher Krawtschuk, the Chief Financial Officer of bluebird bio, Inc. [BLUE], has been reported to engage in a transaction involving the company's stock. The action took place on March 1, 2024. However, the announcement did not disclose the number of shares transacted, the nature of the shares, the transaction price, or the total value of the shares involved. Additionally, the number of shares held by Krawtschuk after the transaction was not provided. The lack of details in the report leaves the specifics of the transaction unclear.